- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Celsion Corp+ Add to Watchlist
CLSN:US3.2500 USD 0.1500 4.41%
As of 20:10:00 ET on 08/01/2014.
Company Profile for Celsion Corp (CLSN)
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Key Executives for Celsion Corp (CLSN)
|Michael H TardugnoPresident/CEO||Jeffrey W Church "Jeff"CFO/Divisional VP/Secy|
|Khursheed AnwerExec VP/Chief Scientific Ofcr||Nicholas BorysVP/Chief Medical Officer|
|Robert A ReedVP:CMC & Technological Ops|